🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Wuxi People's Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Wuxi People's Hospital as lead sponsor. Synced 26 Sep 2026
3Current trials
3Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Wuxi People's Hospital is the lead sponsor of 3 current clinical trials in our China register. 3 are recruiting patients now. All registered phases are Not applicable. The most-studied condition is Cancer.

ClinicalTrials.gov trials by status

  • Recruiting3100%

Trials by phase

  • Not applicable3100%
01

Clinical trials sponsored by Wuxi People's Hospital

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours
NCT06430502 · ClinicalTrials.gov ↗ · Cancer, PD-L1 Gene Mutation
Not applicable Recruiting 2024-05 China
Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours
NCT06404528 · ClinicalTrials.gov ↗ · Solid Tumors, Adult
Not applicable Recruiting 2023-09 China
The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors
NCT06430515 · ClinicalTrials.gov ↗ · Intratumoral Injection, Cancer
Not applicable Recruiting 2023-09 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Wuxi People's Hospital trials

4 conditions
Cancer2PD-L1 Gene Mutation1Solid Tumors, Adult1Intratumoral Injection1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China33

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Cancer

SponsorTrials
GRAIL4
Peking University Cancer Hospital & Institute4
Our Lady's Hospice and Care Services3
Conjupro Biotherapeutics3
University of Dublin, Trinity College2
Replimune2
Tempus AI2
Elephas2
First Hospital of China Medical University2
Qinghai Red Cross Hospital2

Sponsors with the most current trials registered for this condition.

05

Questions about Wuxi People's Hospital trials

How many clinical trials does Wuxi People's Hospital sponsor?

Wuxi People's Hospital is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Wuxi People's Hospital trials recruiting?

Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.